［12］ Cassano N， Miracapillo A， Coviello C， et al. Treatment of psoriasis vulgaris with the twocompound product calcipotriol/betamethasone dipropionate followed by different formulations of calcipotriol［J］. Clin Drug Investig， 2006， 26(4):227-233.

［13］ Kragballe K， Austad J， Barnes L， et al. Efficacy results of a 52week， randomised， doubleblind， safety study of a calcipotriol/betamethasone dipropionate twocompound product (Daivobet/Dovobet/Taclonex) in the treatment of psoriasis vulgaris ［J］. Dermatology， 2006， 213(4):319-326.

［14］ Duweb G， Alhaddar J， Elsherif B， et al. Calcipotriolbetamethasone ointment versus calcipotriol ointment in the treatment of psoriasis vulgaris［J］. Drugs Exp Clin Res， 2005， 31(56):175-179.

［15］ Eskicirak B， Zemheri E， Cerkezoglu A. The treatment of psoriasis vulgaris: 1% topical methotrexate gel［J］. Int J Dermatol， 2006， 45(8):965-969.

［16］ Rogers C. Calcipotriol (Dovobet) ointment in combination with UVB therapy for psoriasis treatment［J］. Dermatol Nurs， 2006， 18(3):258-261.

［17］ Abe M， Syuto T， Hasegawa M， et al. Daily versus intermittent application of highconcentration tacalcitol ointment in combination with lowdose cyclosporin for psoriasis vulgaris ［J］. J Dermatol， 2006， 33(2):108-111.

［18］ Veraldi S， Caputo R， Pacifico A， et al. Short contact therapy with tazarotene in psoriasis vulgaris ［J］. Dermatology， 2006， 212(3):235-237.

［19］ Wu SX， Guo NR. Clinical observation on effect of triptolide tablet in treating patients with psoriasis vulgaris ［J］. Chin J Integr Med， 2005， 11(2):147-148.

［20］ Magliocco MA， Pandya K， Dombrovskiy V， et al. A randomized， doubleblind， vehiclecontrolled， bilateral comparison trial of bexarotene gel 1% versus vehicle gel in combination with narrowband UVB phototherapy for moderate to severe psoriasis vulgaris［J］. J Am Acad Dermatol， 2006， 54(1):115-118.

［21］ Papakostantinou E， Xenos K， Markantonis SL， et al. Efficacy of 2 weeks application of theophylline ointment in psoriasis vulgaris［J］. J Dermatolog Treat， 2005， 16(3):169-170.